Part III: A retrospective analysis of 73 patients with liver transplantation for liver cancer beyond Milan standard ("bridging" treatment group) who received TACE "bridging" therapy in our hospital from January 2013 to January 2019, and 29 patients who received TACE "" Bridging" treatment, 44 patients received DEB-TACE "bridging" treatment, the same as the previous cohort.
正在翻译中..